NCT02944474View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Healthy Subjects
Interventions
DRUG

Lucerastat

Capsule for oral administration containing lucerastat

DRUG

Placebo

Placebo capsules matching lucerastat capsules

Trial Locations (1)

EH14 4AP

Investigator Site, Edinburgh

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY